Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for recovery quality after laparoscopic hysterectomy
ChiCTR2200065556Phase 4Not yet recruiting
- Sponsor
- Gansu Provincial Maternity and Child Care Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Benign Uterine Neoplasm (2 arms), sponsored by Gansu Provincial Maternity and Child Care Hospital. Primary endpoints: Quality of Recovery-15, Pittsburgh Sleep Quality Index and 8 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Benign Uterine Neoplasm
Beyond the preview
Go deeper on ChiCTR2200065556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065556.